Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma

This publication has 14 references indexed in Scilit:

• Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: A comparative study
  Clinical Radiology, 1993
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome
  Digestive Diseases and Sciences, 1993
• Localization of neuroendocrine tumours and insulinomas using radiolabeled somatostatin analogues, ¹²³ I‐Try³‐octreotide and ¹¹¹in‐pentatreitide
  Clinical Endocrinology, 1993
• Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors.
  Radiology, 1993
• Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography
  New England Journal of Medicine, 1992
• Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors
  New England Journal of Medicine, 1990
• Gastrinomas: comparison of MR imaging with CT, angiography, and US.
  Radiology, 1989
• LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
  The Lancet, 1989
• Usefulness of Selective Arterial Secretin Injection Test for Localization of Gastrinoma in the Zollinger-Ellison Syndrome
  Annals of Surgery, 1987